Boston Scientific (BSX) +5.6% premarket following its Q1 EPS beat and after it gives Q2 guidance...

|About: Boston Scientific Corpora... (BSX)|By:, SA News Editor

Boston Scientific (BSX) +5.6% premarket following its Q1 EPS beat and after it gives Q2 guidance of $0.14-$0.17 vs. consensus of $0.10. Boston also expects revenue of $1.85B-$1.95B vs. $1.9B forecasts. Q1 net profit surged over threefold to $113M due to fewer one-time items.